497 related articles for article (PubMed ID: 17584325)
1. Psoriasiform and pustular eruption induced by infliximab.
Takahashi H; Hashimoto Y; Ishida-Yamamoto A; Ashida T; Kohgo Y; Iizuka H
J Dermatol; 2007 Jul; 34(7):468-72. PubMed ID: 17584325
[TBL] [Abstract][Full Text] [Related]
2. Psoriasis induced by tumor necrosis factor-alpha antagonist therapy: a case series.
Cohen JD; Bournerias I; Buffard V; Paufler A; Chevalier X; Bagot M; Claudepierre P
J Rheumatol; 2007 Feb; 34(2):380-5. PubMed ID: 17013997
[TBL] [Abstract][Full Text] [Related]
3. Psoriasis induced by anti-tumor necrosis factor therapy: a paradoxical adverse reaction.
Sfikakis PP; Iliopoulos A; Elezoglou A; Kittas C; Stratigos A
Arthritis Rheum; 2005 Aug; 52(8):2513-8. PubMed ID: 16052599
[TBL] [Abstract][Full Text] [Related]
4. Histopathologic spectrum of psoriasiform skin reactions associated with tumor necrosis factor-α inhibitor therapy. A study of 16 biopsies.
Laga AC; Vleugels RA; Qureshi AA; Velazquez EF
Am J Dermatopathol; 2010 Aug; 32(6):568-73. PubMed ID: 20520526
[TBL] [Abstract][Full Text] [Related]
5. Psoriasis and psoriatic arthritis induced in a patient treated with infliximab for Crohn's disease.
Tichy M; Tichy M; Kopova R; Sternbersky J; Ditrichova D
J Dermatolog Treat; 2012 Jun; 23(3):208-11. PubMed ID: 21254868
[TBL] [Abstract][Full Text] [Related]
6. Psoriasiform eruption induced by infliximab.
Verea MM; Del Pozo J; Yebra-Pimentel MT; Porta A; Fonseca E
Ann Pharmacother; 2004 Jan; 38(1):54-7. PubMed ID: 14742794
[TBL] [Abstract][Full Text] [Related]
7. Occurrence of pustular psoriasis after treatment of Crohn disease with infliximab.
Pourciau C; Shwayder T
Pediatr Dermatol; 2010; 27(5):539-40. PubMed ID: 20796241
[TBL] [Abstract][Full Text] [Related]
8. The enigmatic development of psoriasis and psoriasiform lesions during anti-TNF therapy: a review.
Grinblat B; Scheinberg M
Semin Arthritis Rheum; 2008 Feb; 37(4):251-5. PubMed ID: 17640718
[TBL] [Abstract][Full Text] [Related]
9. Cutaneous manifestations in inflammatory bowel diseases: eight cases of psoriasis induced by anti-tumor-necrosis-factor antibody therapy.
Passarini B; Infusino SD; Barbieri E; Varotti E; Gionchetti P; Rizzello F; Morselli C; Tambasco R; Campieri M
Dermatology; 2007; 215(4):295-300. PubMed ID: 17911986
[TBL] [Abstract][Full Text] [Related]
10. Infliximab and adalimumab-induced psoriasis in Crohn's disease: a paradoxical side effect.
Iborra M; Beltrán B; Bastida G; Aguas M; Nos P
J Crohns Colitis; 2011 Apr; 5(2):157-61. PubMed ID: 21453886
[TBL] [Abstract][Full Text] [Related]
11. [Flexural psoriasis induced by infliximab and adalimumab in a patient with Crohn's disease].
Avila Alvarez A; García-Alonso L; Solar Boga A; García-Silva J
An Pediatr (Barc); 2009 Mar; 70(3):278-81. PubMed ID: 19409245
[TBL] [Abstract][Full Text] [Related]
12. [Infliximab-induced pustular psoriasis in a patient with Crohn's disease].
Monteagudo Sánchez B; Cabanillas M; Ortiz-Marin S; Gallego-Ojea JC
Gastroenterol Hepatol; 2009 Mar; 32(3):175-6. PubMed ID: 19233516
[No Abstract] [Full Text] [Related]
13. Anti-tumor necrosis factor alpha-induced psoriasiform eruptions: three further cases and current overview.
Pirard D; Arco D; Debrouckere V; Heenen M
Dermatology; 2006; 213(3):182-6. PubMed ID: 17033165
[TBL] [Abstract][Full Text] [Related]
14. Psoriasis induced by infliximab in a patient suffering from Crohn's disease.
Manni E; Barachini P
Int J Immunopathol Pharmacol; 2009; 22(3):841-4. PubMed ID: 19822070
[TBL] [Abstract][Full Text] [Related]
15. Sarcoidosis during infliximab therapy for Crohn's disease.
Takahashi H; Kaneta K; Honma M; Ishida-Yamamoto A; Ashida T; Kohgo Y; Ohsaki Y; Iizuka H
J Dermatol; 2010 May; 37(5):471-4. PubMed ID: 20536653
[TBL] [Abstract][Full Text] [Related]
16. A case of generalized psoriasiform and pustular eruption induced by infliximab: evidence for skin-homing Th17 in the pathogenesis.
Teraki Y; Tanaka S; Hitomi K; Izaki S
Br J Dermatol; 2010 Dec; 163(6):1347-51. PubMed ID: 20731653
[No Abstract] [Full Text] [Related]
17. Cutaneous adverse reaction to infliximab: report of psoriasis developing in 3 patients.
Severs GA; Lawlor TH; Purcell SM; Adler DJ; Thompson R
Cutis; 2007 Sep; 80(3):231-7. PubMed ID: 17956013
[TBL] [Abstract][Full Text] [Related]
18. [Ustekinumab in a patient with Crohn's disease and anti-TNF-α-induced psoriasis].
Sansó Sureda A; Rocamora Durán V; Sapiña Camaró A; Royo Escosa V; Bosque López MJ
Gastroenterol Hepatol; 2011 Oct; 34(8):546-50. PubMed ID: 21665330
[TBL] [Abstract][Full Text] [Related]
19. Cytokine imbalance with increased production of interferon-alpha in psoriasiform eruptions associated with antitumour necrosis factor-alpha treatments.
Seneschal J; Milpied B; Vergier B; Lepreux S; Schaeverbeke T; Taïeb A
Br J Dermatol; 2009 Nov; 161(5):1081-8. PubMed ID: 19681863
[TBL] [Abstract][Full Text] [Related]
20. New-onset psoriatic palmoplantaris pustulosis following infliximab therapy: a class effect?
Roux CH; Brocq O; Leccia N; Giacchero D; Breuil V; Albert C; Lacour J; Perrin C; Euller-Ziegler L
J Rheumatol; 2007 Feb; 34(2):434-7. PubMed ID: 17295430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
